Clinical Trial Update: Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial [NA]

View source ↗

Summary

The UPRISE trial is investigating a urine-based screening method combined with MRI for early detection of prostate cancer and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Prostate Carcinoma | NA | Status: NOT_YET_RECRUITING